- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Hypertrophy in Hungary
Total 222 results
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
Hoffmann-La RocheCompletedBreast CancerEstonia, Hungary, Turkey, Israel, Slovakia, Bulgaria, Lithuania, Macedonia, The Former Yugoslav Republic of
-
ETOP IBCSG Partners FoundationTerminatedBreast CancerItaly, Australia, Belgium, Switzerland, Slovenia, Hungary, Sweden, New Zealand, Romania
-
PfizerTerminatedTriple Negative Breast NeoplasmsSpain, United Kingdom, United States, Italy, Hungary, Poland
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupRecruitingNode-positive Breast CancerGreece, Switzerland, Hungary, Austria, Germany, Italy, Lithuania, Argentina, Croatia
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
FEMPHARMA Kft.RecruitingVulvovaginal Candidiasis | Vaginal Yeast InfectionsHungary
-
ETOP IBCSG Partners FoundationHoffmann-La RocheRecruitingBreast CancerIreland, Italy, Germany, Spain, Hungary, France, Sweden, Switzerland
-
AstraZenecaCompletedBreast CancerSweden, Czech Republic, France, Spain, United Kingdom, Hungary, Portugal
-
ETOP IBCSG Partners FoundationCompletedBreast CancerItaly, Switzerland, Australia, Peru, South Africa, Chile, Belgium, Brazil, Romania, Hungary, Nigeria
-
PfizerCompletedEarly Breast CancerCzechia, Serbia, Slovakia, United States, Belarus, Hungary, Ukraine, Italy, Poland, Russian Federation
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
Central European Cooperative Oncology GroupCompletedMetastatic Breast CancerSerbia, Israel, Croatia, Hungary, Poland, Bosnia and Herzegovina, Latvia, Slovakia, Austria, Czechia, Bulgaria, Romania
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, China, Hungary, Singapore, Australia, Russian Federation, Hong Kong, Brazil, Croatia, Korea, Republic of
-
SandozCompletedBreast Cancer | Chemotherapy Associated NeutropeniaCzech Republic, Hungary, Latvia, Russian Federation, Slovakia, Ukraine
-
Zeno Alpha Inc.CompletedBreast CancerUnited States, Belarus, Bosnia and Herzegovina, Czechia, Hungary, Lithuania, Russian Federation, Serbia, Ukraine
-
SanofiCompletedBreast NeoplasmsSpain, Italy, Australia, Czech Republic, Germany, Hungary, Ireland, Israel, New Zealand, Portugal, Slovenia, Slovakia, Austria, Sweden, United Kingdom, Belgium, Brazil, Chile, Denmark, South Africa, Switzerland
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
Daehwa Pharmaceutical Co., Ltd.Active, not recruitingRecurrent or Metastatic Breast CancerChina, Korea, Republic of, Serbia, Bulgaria, Hungary
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and... and other collaboratorsCompletedBreast Cancer | Infertility | Menopausal SymptomsItaly, Australia, Switzerland, Belgium, Hungary, New Zealand
-
Hoffmann-La RocheActive, not recruitingTriple-Negative Breast CancerItaly, Portugal, Slovenia, Spain, Romania, France, Czechia, Argentina, Chile, Hungary, Mexico, Peru, Poland
-
PfizerArvinas Estrogen Receptor, Inc.Active, not recruitingBreast CancerSpain, United States, China, Japan, Australia, Italy, Switzerland, Hungary, Brazil, Slovakia
-
AstraZenecaCompletedNeoplasms | Breast Cancer | Breast NeoplasmsBrazil, Bulgaria, Czech Republic, Peru, Spain, United Kingdom, Sweden, Hungary, Belgium, Canada, Italy, France, Panama, Switzerland
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerFrance, Hong Kong, Korea, Republic of, Russian Federation, Spain, United States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Cyprus, Czech Republic, Egypt, Estonia, ... and more
-
Queen Mary University of LondonCompletedBreast CancerIreland, United Kingdom, Switzerland, Australia, Belgium, Chile, Denmark, Finland, Germany, Hungary, Italy, Malta, Portugal, Turkey
-
Hoffmann-La RocheCompletedBreast CancerItaly, Spain, China, Taiwan, Russian Federation, Canada, Germany, Austria, Hungary, Belgium, Australia, Brazil, Mexico, Poland, Panama
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
Mylan Inc.Mylan GmbHCompletedBreast Neoplasms | Chemotherapy-Induced Febrile NeutropeniaBulgaria, Georgia, Germany, Hungary, Poland, Ukraine
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
MedImmune LLCCompletedHormone-sensitive, HER-2 Negative Metastatic Breast CancerSpain, United States, Belgium, France, United Kingdom, Canada, Israel, Germany, Hungary, Poland, Bahamas
-
Mylan Inc.Mylan GmbHCompletedBreast CancerSlovakia, Brazil, Chile, Georgia, Hungary, India, Latvia, Peru, Romania, Russian Federation, Serbia, South Africa, Thailand, Turkey, Ukraine
-
PfizerCompletedBreast CancerKorea, Republic of, United States, Spain, Germany, Ireland, Hungary, Canada, France, Italy, Russian Federation, South Africa, Ukraine
-
Hoffmann-La RocheRecruitingBreast CancerKorea, Republic of, United States, Israel, Denmark, Argentina, Brazil, Germany, Mexico, Peru, Poland, Spain, Taiwan, South Africa, Netherlands, Czechia, Italy, Australia, Hungary
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerSouth Africa, France, Italy, Taiwan, Hungary, Belgium, Spain, Austria, Netherlands, Poland, Russian Federation, United States, Argentina, Brazil, Peru
-
Hoffmann-La RocheCompletedBreast CancerCanada, Germany, Korea, Republic of, Panama, Spain, Turkey, Brazil, Colombia, France, Hungary, Russian Federation, Taiwan, Thailand, Czechia, Italy, Estonia, Peru, South Africa, Sweden, Poland, Israel, Hong Kong, Mexico, Guatemala, Arge... and more
-
Sermonix Pharmaceuticals Inc.RecruitingMetastatic Breast CancerUnited States, France, Belgium, Spain, Israel, Taiwan, United Kingdom, Korea, Republic of, Italy, Australia, Germany, Canada, Czechia, Hungary, Poland, Romania, Singapore, Turkey
-
Pierre Fabre MedicamentCompletedBreast CancerFrance, Poland, Ukraine, United Kingdom, Taiwan, Spain, Belgium, Belarus, Mexico, Bulgaria, India, South Africa, Brazil, Russian Federation, Argentina, Hungary, Italy, Serbia, Switzerland, Czechia, Estonia
-
AstraZenecaActive, not recruitingBreast CancerBelgium, Spain, Italy, United States, Brazil, Czechia, Russian Federation, Chile, Slovakia, Hungary, India, Ukraine, Venezuela, Colombia, Poland, Malta, Mexico
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, Czech Republic, France, Hungary, Japan, Belgium, Canada, Netherlands, Italy
-
Hoffmann-La RocheCompletedBreast CancerHungary, Italy, Spain, France, United Kingdom, Belgium, Germany, Portugal, Poland, Canada, Bulgaria, Mexico
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, South Africa, Austria, Hungary, Germany, Czechia, France, Russian Federation, Thailand, Belgium, Bulgaria, Lithuania, Jordan, Sweden, Finland, Peru, Colombia, Portugal, Canada, Brazil, India, Argentina, Costa Rica
-
AbbVieNSABP Foundation Inc; German Breast Group; US Oncology Research; Grupo Espanol...CompletedTriple Negative Breast CancerUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Breast CancerKorea, Republic of, Taiwan, Hong Kong, United States, Japan, Croatia, United Kingdom, Hungary, Australia, Canada, Serbia, Singapore, South Africa, Poland, Spain, Russian Federation, Romania, Austria, Belgium, Bulgaria, Czechia, Fr... and more